Penalized Poisson model for network meta-analysis of individual patient time-to-event data

02/26/2021
by   Edouard Ollier, et al.
0

Network meta-analysis (NMA) allows the combination of direct and indirect evidence from a set of randomized clinical trials. Performing NMA using individual patient data (IPD) is considered as a gold standard approach as it provides several advantages over NMA based on aggregate data. For example, it allows to perform advanced modelling of covariates or covariate-treatment interactions. An important issue in IPD NMA is the selection of influential parameters among terms that account for inconsistency, covariates, covariate-by-treatment interactions or non-proportionality of treatments effect for time to event data. This issue has not been deeply studied in the literature yet and in particular not for time-to-event data. A major difficulty is to jointly account for between-trial heterogeneity which could have a major influence on the selection process. The use of penalized generalized mixed effect model is a solution, but existing implementations have several shortcomings and an important computational cost that precludes their use for complex IPD NMA. In this article, we propose a penalized Poisson regression model to perform IPD NMA of time-to-event data. It is based only on fixed effect parameters which improve its computational cost over the use of random effects. It could be easily implemented using existing penalized regression package. Computer code is shared for implementation. The methods were applied on simulated data to illustrate the importance to take into account between trial heterogeneity during the selection procedure. Finally, it was applied to an IPD NMA of overall survival of chemotherapy and radiotherapy in nasopharyngeal carcinoma.

READ FULL TEXT
research
09/22/2020

Subgroup identification in individual patient data meta-analysis using model-based recursive partitioning

Model-based recursive partitioning (MOB) can be used to identify subgrou...
research
08/20/2019

Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint

The recent 21st Century Cures Act propagates innovations to accelerate t...
research
04/28/2020

Survival Analysis Using a 5-Step Stratified Testing and Amalgamation Routine in Randomized Clinical Trials

Randomized clinical trials are often designed to assess whether a test t...
research
10/31/2022

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Individualizing treatment assignment can improve outcomes for diseases w...
research
09/21/2021

Network meta-analysis of rare events using penalized likelihood regression

Network meta-analysis (NMA) of rare events has attracted little attentio...
research
05/03/2021

Efficient Integration of Aggregate Data and Individual Patient Data in One-Way Mixed Models

Often both Aggregate Data (AD) studies and Individual Patient Data (IPD)...

Please sign up or login with your details

Forgot password? Click here to reset